VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 74 filers reported holding VERVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,579,213 | -25.5% | 2,532,369 | +5.4% | 0.09% | -20.5% |
| Q2 2023 | $45,049,500 | +30.0% | 2,402,640 | 0.0% | 0.11% | +28.7% |
| Q1 2023 | $34,646,069 | -13.8% | 2,402,640 | +15.6% | 0.09% | -21.6% |
| Q4 2022 | $40,214,892 | -33.1% | 2,078,289 | +18.8% | 0.11% | -36.9% |
| Q3 2022 | $60,103,000 | +258.3% | 1,749,737 | +59.4% | 0.18% | +282.6% |
| Q2 2022 | $16,775,000 | +3.5% | 1,097,837 | +54.6% | 0.05% | +24.3% |
| Q1 2022 | $16,208,000 | +18.8% | 710,237 | +92.0% | 0.04% | +48.0% |
| Q4 2021 | $13,642,000 | -21.6% | 370,000 | 0.0% | 0.02% | -24.2% |
| Q3 2021 | $17,390,000 | -22.0% | 370,000 | 0.0% | 0.03% | -21.4% |
| Q2 2021 | $22,293,000 | – | 370,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,008,809 | $26,636,807 | 17.30% |
| Alphabet Inc. | 10,549,086 | $139,880,880 | 8.98% |
| Casdin Capital, LLC | 2,954,710 | $39,179,455 | 4.34% |
| MPM BioImpact LLC | 857,940 | $11,376,284 | 3.04% |
| Saltoro Capital, LP | 66,500 | $881,790 | 0.79% |
| ARK Investment Management | 5,200,567 | $68,959,525 | 0.53% |
| Redmile Group, LLC | 809,777 | $10,737,643 | 0.51% |
| Ikarian Capital, LLC | 2,413 | $3,199,638 | 0.38% |
| Logos Global Management LP | 215,000 | $2,850,900 | 0.38% |
| Nikko Asset Management Americas, Inc. | 2,147,243 | $28,429,497 | 0.34% |